124 related articles for article (PubMed ID: 27246038)
21. Pathogenesis of gastritis in ileitis-prone SAMP1/Yit mice.
Ernst PB; Wiznerowicz EB; Feldman SH; Tung KS
Keio J Med; 2011; 60(2):65-8. PubMed ID: 21720202
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D treatment attenuates 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis but not oxazolone-induced colitis.
Liu T; Shi Y; Du J; Ge X; Teng X; Liu L; Wang E; Zhao Q
Sci Rep; 2016 Sep; 6():32889. PubMed ID: 27620138
[TBL] [Abstract][Full Text] [Related]
23. In Vitro Characterization of Gut Microbiota-Derived Commensal Strains: Selection of
Cuffaro B; Assohoun ALW; Boutillier D; Súkeníková L; Desramaut J; Boudebbouze S; Salomé-Desnoulez S; Hrdý J; Waligora-Dupriet AJ; Maguin E; Grangette C
Cells; 2020 Sep; 9(9):. PubMed ID: 32947881
[TBL] [Abstract][Full Text] [Related]
24. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
Sartor RB
Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
[TBL] [Abstract][Full Text] [Related]
25. Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease.
Zeng JQ; Xu CD; Zhou T; Wu J; Lin K; Liu W; Wang XQ
World J Gastroenterol; 2015 Jan; 21(1):187-95. PubMed ID: 25574091
[TBL] [Abstract][Full Text] [Related]
26. Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model.
Van Montfrans C; Rodriguez Pena MS; Pronk I; Ten Kate FJ; Te Velde AA; Van Deventer SJ
Gastroenterology; 2002 Dec; 123(6):1865-76. PubMed ID: 12454844
[TBL] [Abstract][Full Text] [Related]
27. The Intestinal Microbiota in Inflammatory Bowel Disease.
Becker C; Neurath MF; Wirtz S
ILAR J; 2015; 56(2):192-204. PubMed ID: 26323629
[TBL] [Abstract][Full Text] [Related]
28. TNBS-colitis.
Neurath M; Fuss I; Strober W
Int Rev Immunol; 2000; 19(1):51-62. PubMed ID: 10723677
[TBL] [Abstract][Full Text] [Related]
29. Pivotal roles of interleukin-6 in transmural inflammation in murine T cell transfer colitis.
Kitamura K; Nakamoto Y; Kaneko S; Mukaida N
J Leukoc Biol; 2004 Dec; 76(6):1111-7. PubMed ID: 15339938
[TBL] [Abstract][Full Text] [Related]
30. Chemically induced mouse models of intestinal inflammation.
Wirtz S; Neufert C; Weigmann B; Neurath MF
Nat Protoc; 2007; 2(3):541-6. PubMed ID: 17406617
[TBL] [Abstract][Full Text] [Related]
31. Expression of Ecto-nucleoside Triphosphate Diphosphohydrolases-2 and -3 in the Enteric Nervous System Affects Inflammation in Experimental Colitis and Crohn's Disease.
Feldbrügge L; Moss AC; Yee EU; Csizmadia E; Mitsuhashi S; Longhi MS; Sandhu B; Stephan H; Wu Y; Cheifetz AS; Müller CE; Sévigny J; Robson SC; Jiang ZG
J Crohns Colitis; 2017 Sep; 11(9):1113-1123. PubMed ID: 28472257
[TBL] [Abstract][Full Text] [Related]
32. miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12β during murine colitis and human Crohn's disease.
Huang Z; Shi T; Zhou Q; Shi S; Zhao R; Shi H; Dong L; Zhang C; Zeng K; Chen J; Zhang J
Gut; 2014 Aug; 63(8):1247-57. PubMed ID: 24000293
[TBL] [Abstract][Full Text] [Related]
33. N-(3', 4'-dimethoxycinnamonyl) anthranilic acid alleviated experimental colitis by inhibiting autoimmune response and inducing CD4+ CD25+ regulatory T cells production.
Wen Q; Zhou L; Chen H; Zhang Y
J Gastroenterol Hepatol; 2013 Aug; 28(8):1330-8. PubMed ID: 23663055
[TBL] [Abstract][Full Text] [Related]
34. Exosomes derived from interleukin-10-treated dendritic cells can inhibit trinitrobenzene sulfonic acid-induced rat colitis.
Yang X; Meng S; Jiang H; Chen T; Wu W
Scand J Gastroenterol; 2010 Oct; 45(10):1168-77. PubMed ID: 20469967
[TBL] [Abstract][Full Text] [Related]
35. Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease.
Van den Brande JM; Koehler TC; Zelinkova Z; Bennink RJ; te Velde AA; ten Cate FJ; van Deventer SJ; Peppelenbosch MP; Hommes DW
Gut; 2007 Apr; 56(4):509-17. PubMed ID: 17082252
[TBL] [Abstract][Full Text] [Related]
36. Methods of inducing inflammatory bowel disease in mice.
Maxwell JR; Brown WA; Smith CL; Byrne FR; Viney JL
Curr Protoc Pharmacol; 2009 Dec; Chapter 5():Unit5.58. PubMed ID: 22294404
[TBL] [Abstract][Full Text] [Related]
37. Regulation of gut inflammation and th17 cell response by interleukin-21.
Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
[TBL] [Abstract][Full Text] [Related]
38. Immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
Hibi T; Iwao Y; Yajima T; Inoue N; Ueno Y; Takaishi H; Watanabe M; Ishii H
J Gastroenterol; 1995 Nov; 30 Suppl 8():121-3. PubMed ID: 8563872
[TBL] [Abstract][Full Text] [Related]
39. High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis.
Holgersen K; Kutlu B; Fox B; Serikawa K; Lord J; Hansen AK; Holm TL
J Crohns Colitis; 2015 Jun; 9(6):492-506. PubMed ID: 25795566
[TBL] [Abstract][Full Text] [Related]
40. Distinct Microbial Communities Trigger Colitis Development upon Intestinal Barrier Damage via Innate or Adaptive Immune Cells.
Roy U; Gálvez EJC; Iljazovic A; Lesker TR; Błażejewski AJ; Pils MC; Heise U; Huber S; Flavell RA; Strowig T
Cell Rep; 2017 Oct; 21(4):994-1008. PubMed ID: 29069606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
